Eljack, S.; David, S.; Chourpa, I.; Faggad, A.; Allard-Vannier, E.
Formulation of Lipid-Based Nanoparticles for Simultaneous Delivery of Lapatinib and Anti-Survivin siRNA for HER2+ Breast Cancer Treatment. Pharmaceuticals 2022, 15, 1452.
https://doi.org/10.3390/ph15121452
AMA Style
Eljack S, David S, Chourpa I, Faggad A, Allard-Vannier E.
Formulation of Lipid-Based Nanoparticles for Simultaneous Delivery of Lapatinib and Anti-Survivin siRNA for HER2+ Breast Cancer Treatment. Pharmaceuticals. 2022; 15(12):1452.
https://doi.org/10.3390/ph15121452
Chicago/Turabian Style
Eljack, Sahar, Stephanie David, Igor Chourpa, Areeg Faggad, and Emilie Allard-Vannier.
2022. "Formulation of Lipid-Based Nanoparticles for Simultaneous Delivery of Lapatinib and Anti-Survivin siRNA for HER2+ Breast Cancer Treatment" Pharmaceuticals 15, no. 12: 1452.
https://doi.org/10.3390/ph15121452
APA Style
Eljack, S., David, S., Chourpa, I., Faggad, A., & Allard-Vannier, E.
(2022). Formulation of Lipid-Based Nanoparticles for Simultaneous Delivery of Lapatinib and Anti-Survivin siRNA for HER2+ Breast Cancer Treatment. Pharmaceuticals, 15(12), 1452.
https://doi.org/10.3390/ph15121452